Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELECT: Erythromycin in COPD
NCT00147667Phase 3Unknown
- Sponsor
- UCL Medical School
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erythromycin in chronic obstructive pulmonary disease (COPD), sponsored by UCL Medical School. Status: unknown.
02
Drugs
erythromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00147667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147667.